−500.00 KEUR
220.82 M
About HYBRIGENICS
Sector
CEO
Léone Atayi
Headquarters
Gallargues-le-Montueux
Website
Founded
1998
ISIN
FR0004153930
FIGI
BBG000TXWWM5
Hybrigenics SA operates as a biopharmaceutical company which engages in the research and development of targets and therapies for the treatment of proliferative diseases. It develops inecalcitol for the treatment of prostate cancer, acute and chronic lymphocytic leukemia, and acute and chronic myeloid leukemia. The company was founded by Arthur Donny Strosberg on December 29, 1997 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALHYG is 0.01 EUR — it has decreased by 4.07% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange HYBRIGENICS stocks are traded under the ticker ALHYG.
Yes, you can track HYBRIGENICS financials in yearly and quarterly reports right on TradingView.
Like other stocks, ALHYG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HYBRIGENICS stock right from TradingView charts — choose your broker and connect to your account.